Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Myriad Genetics Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 199 | 191 | −8 |
| Shares | 79.9M | 81.5M | +1.59M (+2.0%) |
| Value | $1.46B | $1.55B | +$99.6M (+6.8%) |
New holders (19)
Institutions that held Myriad Genetics Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 1,266,235 | $24.2M | 0.03% |
| Candriam Luxembourg S.C.A. | 44,157 | $843.0K | 0.01% |
| AlphaCrest Capital Management LLC | 30,238 | $577.0K | 0.04% |
| Squarepoint Ops LLC | 25,888 | $494.0K | 0.00% |
| Teachers Retirement System of the State of Kentucky | 21,645 | $413.0K | 0.00% |
| Walleye Capital LLC | 21,246 | $405.0K | 0.01% |
| Jane Street Group, LLC | 20,567 | $392.0K | 0.00% |
| Virginia Retirement Systems Et Al | 11,400 | $217.5K | 0.00% |
| Globeflex Capital L P | 10,545 | $201.0K | 0.03% |
| Aquatic Capital Management LLC | 7,200 | $137.0K | 0.01% |
| Lazard Asset Management LLC | 1,236 | $23.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 755 | $14.0K | 0.01% |
| Dark Forest Capital Management LP | 504 | $10.0K | 0.00% |
| EverSource Wealth Advisors, LLC | 508 | $9.00K | 0.00% |
| Wipfli Financial Advisors LLC, | 379 | $7.00K | 0.00% |
| Plante Moran Financial Advisors, LLC | 244 | $5.00K | 0.00% |
| De Burlo Group Inc | 100 | $1.91K | 0.00% |
| Farmers & Merchants Investments Inc | 54 | $1.00K | 0.00% |
| SJS Investment Consulting Inc. | 7 | $0 | 0.00% |
Sold out (27)
Institutions that held Myriad Genetics Inc at the end of Q2 2022 and filed for Q3 2022 without it.